Biotherapeutics News and Research

RSS
Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

Bruker launches timsTOF fleX with ESI/MALDI capability for SpatialOMx at ASMS 2019

Sartorius Stedim Biotech launches new SIMCA 16 software for multivariate data analytics

Sartorius Stedim Biotech launches new SIMCA 16 software for multivariate data analytics

Sartorius Stedim Biotech introduces new ambr 15 cell culture microbioreactor system

Sartorius Stedim Biotech introduces new ambr 15 cell culture microbioreactor system

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

Celltrion and iProgen Biotech announce partnership for development of novel ADCs

Probing Submicron Protein Aggregation using Asymmetrical Flow Field-Flow Fractionation, AF4, and Light Scattering

Probing Submicron Protein Aggregation using Asymmetrical Flow Field-Flow Fractionation, AF4, and Light Scattering

Injection of genetically modified virus effectively treats metastatic melanoma patients

Injection of genetically modified virus effectively treats metastatic melanoma patients

RBSC announces partnership with Mitacs to develop and test yeast-based RNAi technology

RBSC announces partnership with Mitacs to develop and test yeast-based RNAi technology

Bio-Rad publishes new paper on generation, characterization of complex-specific antibodies

Bio-Rad publishes new paper on generation, characterization of complex-specific antibodies

High-performing MS device reaches new level in characterizing protein impurities

High-performing MS device reaches new level in characterizing protein impurities

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

MD Anderson Cancer Center and 4D pharma team up to evaluate live biotherapeutic oncology pipeline

Stand Up to Cancer supports potential approach to more efficiently target pancreatic cancer

Stand Up to Cancer supports potential approach to more efficiently target pancreatic cancer

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

Forbius initiates Phase 2a trial evaluating efficacy, safety of AVID100 in patients with squamous NSCLC

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

LineaRx signs agreement with Takis/Evvivax to develop linear-DNA based anti-cancer vaccines

Cancer Research UK invests £14 million to transform London into cancer biotherapeutics hub

Cancer Research UK invests £14 million to transform London into cancer biotherapeutics hub

New polyclonal immunotherapy successfully neutralizes Ebola virus

New polyclonal immunotherapy successfully neutralizes Ebola virus

Merck collaborates with Solvias to offer new MAT kit for pyrogen detection

Merck collaborates with Solvias to offer new MAT kit for pyrogen detection

Oncolytic virus alerts the immune system to attack tumors

Oncolytic virus alerts the immune system to attack tumors

UTokyo enters into agreement for developing personalized cancer vaccine

UTokyo enters into agreement for developing personalized cancer vaccine

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

TGen awarded $2.5 million SU2C grant to test new method of treating pancreatic cancer

New cell therapy restores movement in people with paralyzing spinal cord injuries

New cell therapy restores movement in people with paralyzing spinal cord injuries